Design Therapeutics competitorsClear all
Design Therapeutics's top competitors include Kamada Pharmaceuticals, Immunicum and Escient Pharmaceuticals.
 Design Therapeutics Design Therapeutics is a biotechnology company that develops therapies for serious degenerative disorders caused by nucleotide repeat expansions. |  Kamada Pharmaceuticals Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications. |  Immunicum Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors. |  Escient Pharmaceuticals Escient Pharmaceuticals is a biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications. | |
Founding Date | Founding Date 2017 | Founding Date 1990 | Founding Date 2002 | Founding Date N/A |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Carlsbad, US HQ New York, US San Diego, US San Diego, US | Locations Rehovot, IL HQ Beit Kama, IL | Locations Stockholm, SE HQ Leiden, NL | Locations San Diego, US HQ |
Employees | Employees 22 | Employees 408 | Employees 29 | Employees 39 |
Valuation ($) | Valuation ($) 634.6 m | Valuation ($) 209.5 m | Valuation ($) 47.1 m | Valuation ($) N/A |
Alexa Website Rank | Alexa Website Rank 358868 | Alexa Website Rank 859663 | Alexa Website Rank 546679 | Alexa Website Rank 136663 |
Employee Rating | Employee Rating N/A | Employee Rating 3.7 | Employee Rating N/A | Employee Rating N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $103.6m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ($52.8m) (FY, 2021) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $50.9m (FY, 2021) | Gross profit kr31k (FY, 2021) | Gross profit N/A |
Net income | Net income N/A | Net income ($2.2m) (FY, 2021) | Net income (kr133.4m) (FY, 2021) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 45m | Total funding raised $ 90m | Total funding raised N/A | Total funding raised $ 117.5m |
For sources of this data, please see the company profile
View company profiles
Kamada Pharmaceuticals
HQ
Rehovot, IL
Employees
408
Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.
View companyImmunicum
HQ
Stockholm, SE
Employees
29
Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors.
View companyEscient Pharmaceuticals
HQ
San Diego, US
Employees
39
Escient Pharmaceuticals is a biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications.
View company